Dr. Robin M. Ciocca, DO
Surgical Oncology (Surgical Oncology Physician)
100 E Lancaster Ave, Suite 275 Lankenau Med Sci Bldg.
Wynnewood, PA 19096
- Medicare participating
At a glance
- Medical school
- Philadelphia College of Osteopathic Medicine (2001)
- Years since graduation
- 25
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 347
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2001Medical school: Philadelphia College of Osteopathic Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Surgical Oncology Physician primary
PA license OS012361
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Main Line Hospital Lankenau Wynnewood, PA
- Paoli Hospital Paoli, PA
- Bryn Mawr Hospital Bryn Mawr, PA
- Riddle Memorial Hospital Media, PA
Medical groups
- Main Line Healthcare (1,184 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 347
- Services billed
- 467
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 312 | 291 |
| New patient office or other outpatient visit, 45-59 minutes | 70 | 70 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 21 | 21 |
| Partial removal of breast | 16 | 15 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 8 companies reported 18 payments worth $610 in total to this clinician.
| Stryker Corporation | $173 |
|---|---|
| AstraZeneca Pharmaceuticals LP | $111 |
| Eisai Inc. | $95.96 |
| Sobi, Inc | $83.55 |
| Lilly USA, LLC | $64.46 |
| Puma Biotechnology, Inc. | $29.47 |
| Merck Sharp & Dohme LLC | $26.85 |
| Daiichi Sankyo Inc. | $25.23 |
| Food and Beverage | $610 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.